Somantadine
| Clinical data | |
|---|---|
| Other names | PR 741-976; a,a-Dimethyl-1-adamantaneethylamine; [2-(1-Adamantyl)-1,1-dimethylethyl]amine |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C14H25N |
| Molar mass | 207.361 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Somantadine (INN; developmental code name PR 741-976), or somantadine hydrochloride (USAN) in the case of the hydrochloride salt, is an experimental antiviral drug of the adamantane family related to amantadine and rimantadine that was never marketed. It was first described by 1978.